IMMIX BIOPHARMA, INC. (IMMX) Operating income 2020–2025
IMMIX BIOPHARMA, INC. (IMMX) annual operating income history from SEC filings — each fiscal year as reported.
-$30.0MFY2025 · since FY2020: -$453,852 → -$30.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$30.0M | -32.1% |
| FY2024 | -$22.7M | -40.5% |
| FY2023 | -$16.1M | -96.4% |
| FY2022 | -$8.2M | -507.9% |
| FY2021 | -$1.4M | -197.9% |
| FY2020 | -$453,852 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMMX financial trends
IMMX RevenueIMMX Net incomeIMMX Net marginIMMX Gross profitIMMX Gross marginIMMX Operating marginIMMX Operating cash flowIMMX Free cash flowIMMX Capital expendituresIMMX Return on equityIMMX Stock buybacksIMMX Dividends paidIMMX Total assetsIMMX Total liabilitiesIMMX Shareholders’ equityIMMX overview →